Skip to main content
. 2015 Jul 3;8:1603–1610. doi: 10.2147/OTT.S73731

Figure 4.

Figure 4

The expression of various apoptotic proteins (A, B), differentially expressed of apoptotic proteins in human NSCLC PC9 cell lines (C), and DR5 and caspase3 gene expression in PC9 cells in following single agent as well as combination treatment (D).

Notes: The two drug combinations up-regulated DR5, cleaved-caspases 3 and BAX protein expression; and down-regulated FLIP protein expression. A significantly enhanced gene expression is observed in PC9 cells after gefitinib and rmhTRAIL treatment (D).